Literature DB >> 12451373

Treatment of chronic actinic dermatitis with tacrolimus ointment.

Naoko Uetsu1, Hiroyuki Okamoto, Keiko Fujii, Risa Doi, Takeshi Horio.   

Abstract

BACKGROUND: Chronic actinic dermatitis (CAD) is difficult to treat. Topical corticosteroids induce adverse effects after long-term use, especially on light-exposed skin.
OBJECTIVE: Our purpose was to study the effects of tacrolimus ointment in the treatment of elderly patients with CAD.
METHODS: In an open trial, 6 male patients between 51 and 80 years old with CAD applied 0.1% tacrolimus ointment twice a day to the face and neck. According to improvements, the frequency of application was reduced. Sunscreen agents were also applied outdoors.
RESULTS: Tacrolimus ointment effectively treated cutaneous changes in all patients. Symptoms were moderately improved in 2 weeks, and greatly in 4 weeks. A brief and localized irritating sensation occurred in all patients, but no other adverse events developed throughout the study course from 0.5 to 2.5 years.
CONCLUSION: Topical tacrolimus ointment for facial lesions of CAD appears to be effective and well tolerated and may provide long-term benefits.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12451373     DOI: 10.1067/mjd.2002.124703

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  3 in total

Review 1.  Topical tacrolimus and pimecrolimus in the treatment of cutaneous lupus erythematosus: an evidence-based evaluation.

Authors:  Thrasivoulos George Tzellos; Dimitrios Kouvelas
Journal:  Eur J Clin Pharmacol       Date:  2007-12-20       Impact factor: 2.953

2.  Chronic actinic dermatitis with leonine facies and iatrogenic adrenal insufficiency successfully treated with topical tacrolimus.

Authors:  Ploysyne Busaracome; Penpun Wattanakrai; Natta Rajatanavin
Journal:  Case Rep Dermatol       Date:  2011-02-25

3.  Hydrogel or ointment? Comparison of five different galenics regarding tissue breathability and transepidermal water loss.

Authors:  Lars Rüther; Werner Voss
Journal:  Heliyon       Date:  2021-01-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.